最新の試験

EudraCT Number: 2018-001771-21

Sponsor Protocol Number: XL184–311

Start Date:

Sponsor Name: Exelixis, Inc.

Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-...

Medical condition: Radioiodine-Refractory Differentiated Thyroid Cancer which has progressed after prior VEGFR-targeted therapy

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066474	Thyroid cancer	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) BE (Ongoing) FR (Ongoing) AT (Ongoing) HU (Ongoing) ES (Ongoing) PL (Ongoing) CZ (Ongoing) HR (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) RO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-002012-23

Sponsor Protocol Number: SL79.22

Start Date:

Sponsor Name: STALLERGENES

Full Title: A Multi-national Phase IIIb, Double-blind, Placebo-controlled Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years old with Birch Pollen-in...

Medical condition: Birch Pollen-induced Allergic Rhinoconjunctivitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004853	10001728	Allergic rhinoconjunctivitis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: SE (Ongoing) FR (Ongoing) FI (Ongoing) DE (Ongoing) LT (Ongoing) SK (Ongoing) HU (Ongoing) BG (Ongoing) AT (Ongoing) LV (Ongoing) PL (Ongoing) RO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2011-004704-38

Sponsor Protocol Number: GBG70

Start Date:

Sponsor Name: GBG Forschungs GmbH

Full Title: Dual blockage with Afatinib and Trastuzumab as neooadjuvant treatment for patients with lo-cally advanced or operable breast cancer receiving taxane-anthracycline containing chemo-therapy (DAFNE st...

Medical condition: Patients with HER2-positive early breast cancer.

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10065430	HER-2 positive breast cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2015-004904-50

Sponsor Protocol Number: GWEP15100

Start Date:

Sponsor Name: GW Research Ltd

Full Title: A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Cannabidiol (GWP42003-P) in infants with Infantile Spasms following an initial open label pilot study.

Medical condition: Infantile Spasms

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10029205 - Nervous system disorders	10021750	Infantile spasms	PT

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: PL (Completed)

Trial results: View results

EudraCT Number: 2014-005375-91

Sponsor Protocol Number: NN9535-4216

Start Date:

Sponsor Name: Novo Nordisk A/S

Full Title: Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes

Medical condition: Diabetes Mellitus, Type 2

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	100000004861	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed) FI (Completed) DE (Completed) GB (Completed) SK (Completed) LV (Completed) LT (Completed) GR (Completed) ES (Completed) PT (Completed) HR (Completed)

Trial results: View results

EudraCT Number: 2010-022923-31

Sponsor Protocol Number: FIinTIC

Start Date:

Sponsor Name: Medizinische Universität Innsbruck / Univ.-Klinik für Allgem. u. Chirurg. Intensivmedizin

Full Title: A multicenter double-blind, placebo controlled, randomized, pilot trial to assess the efficacy of pre-hospital administration of Fibrinogen Concentrate (FGTW) in trauma patients, presumed to bleed ...

Medical condition: Trauma patients with major bleeding or occult bleeding who received volume replacement

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	100000004866	10018988	Haemorrhage NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) DE (Ongoing) CZ (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-000214-42

Sponsor Protocol Number: 755-201-EB

Start Date:

Sponsor Name: InMed Pharmaceuticals Inc.

Full Title: A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa.

Medical condition: Epidermolysis bullosa

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10014989	Epidermolysis bullosa	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) FR (Completed) AT (Completed) GR (Ongoing) IT (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001624-14

Sponsor Protocol Number: LE3301

Start Date:

Sponsor Name: Pharming Technologies B.V.

Full Title: An Open-Label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 4 to 11 Years) With APDS (Activated Phosphoinositide 3-Kina...

Medical condition: Activated Phosphoinositide 3-Kinase Delta Syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10078281	Activated PI3 kinase delta syndrome	PT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing) NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-004988-30

Sponsor Protocol Number: 23386753

Start Date:

Sponsor Name: Mater Misercordiae Hospital - Department of Anaesthesia

Full Title: PHARMACOKINETICS AND ANALGESIC EFFICACY OF LAEVOBUPIVACAINE, FENTANYL AND CLONIDINE FOR POSTOPERATIVE PARAVERTEBRAL ANAESTHESIA.

Medical condition: We are aiming to provide postoperative analgesia for breast surgery

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: IE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-017347-33

Sponsor Protocol Number: Clofarabine

Start Date:

Sponsor Name: University of Leipzig

Full Title: A multicenter Phase I/II trial investigating the safety and efficacy (CR rate and OS) of low dose AraC with Clofarabine in patients ≥60 years with AML not eligible for conventional Chemotherapy

Medical condition: Acute myeloid leukaemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10000880	Acute myeloid leukaemia	PT
	12.1		10000880	Acute myeloid leukaemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

最新の試験

スポンサーと協力者

医学的状態

薬物療法